ScienceMedia announced their partnership with Apex Mobile Clinical Research (AMCR), a provider of decentralized clinical trial solutions and services to underserved communities. AMCR will be using ScienceMedia's protocol compliance management solution, SMi Trial™, for deploying disease, therapeutic and clinical trial training.
By using mobile technology and home visits by study team healthcare providers (HCPs), AMCR's decentralized model makes participation in clinical research more accessible for physicians and their patients, while keeping the trusted patient-provider relationship intact. AMCR positions the patient's home as the hub for clinical trial activities, eliminating many frequent study-related visits to clinics and hospitals, thus placing patients at the center of the decentralized model.
Deploying ScienceMedia's therapeutic and clinical multimedia content will allow AMCR's staff and partner sites to access on-demand medical-science microlearning courses, thereby speeding protocol competency. Additionally, SMi Trial's training modules will provide for more effective home visits and efficient onboarding of clinical staff.
"Decentralization of clinical trials is a critical and necessary step forward in the research space whose need has become accentuated with the current COVID-19 pandemic," states Stephen Harrison, MD, AMCR's Chief Executive Officer.
As AMCR continues to expand decentralized trial support, AMCR's President and Chief Development Officer, Inge K. Bear, plans to implement SMi TrialD, ScienceMedia's innovative protocol compliance management solution for decentralized trials. Bear asserts, "The implementation of SMi TrialD will ultimately help AMCR collapse patient recruitment and enrollment, expediting the drug development and regulatory approval process by delivering a high-quality, compliant data package with speed and efficiency."
ScienceMedia's CEO, Mark Surles, adds, "We are eager to be partnering with an innovative company who shares our same goals of faster trial recruitment, shorter clinical trial timelines, cost savings, and improved clinical data. This is a unique opportunity to support innovation in the decentralized space that positions the patient at the hub."
Subscribe to our e-Newsletters
Stay up to date with the latest news, articles, and events. Plus, get special offers
from Pharmaceutical Outsourcing – all delivered right to your inbox!
Sign up now!